On April 18, the standardized operation meeting of medical and beauty institutions hosted by new technology and new materials of China plastic and Beauty Association and Bloomage Biotechnology Corporation Limited(688363) co sponsored by China plastic and Beauty Association was successfully held in Beijing. With the increasingly strict official supervision of the medical and beauty industry, 2022 is bound to become the first year of compliance of the medical and beauty industry.
In recent years, the government has carried out unprecedented special rectification on medical beauty, and all departments require to severely crack down on various illegal medical beauty activities and medical beauty counterfeiting / sales. There are two common links of medical and aesthetic adverse events. One is the violation of qualification, that is, the qualification of institutions, medical care and drugs / medical equipment. In terms of qualification violations, fake and shoddy products and unregistered products account for the largest proportion. Second, improper management, which is mainly divided into general management and medical management. General management refers to the management behavior related to the daily operation of medical and American institutions; Medical management includes medical quality control management, case management, operation period management and so on.
Ding Yang, director of the public opinion information center of China plastic and cosmetic association, suggested that in terms of qualification management, medical and aesthetic institutions should strictly comply with relevant laws and regulations, regularly carry out qualification compliance self inspection, strictly manage doctor access and product access, standardize the purchase channels of drugs and medical devices, use regular products in compliance, and strengthen the use management of clinical drugs and medical devices.
Bloomage Biotechnology Corporation Limited(688363) the relevant person in charge of medical beauty division believes that the medical beauty industry urgently needs to establish a standard system, and compliance development is the premise of the establishment of the standard system. With the completion of supervision, the improvement of consumer awareness, the launch of the “three formal platforms” of industry associations and the fight against counterfeiting by various brands, the medical beauty market will quickly enter the stage of standardized and healthy development, and the rise of upstream dragon manufacturers will also benefit from it, reversing the bad phenomenon of “bad money expelling good money” in the past.
